Viral and non-viral vectors for cancer gene therapy

Anticancer Research

Volumn 18, Issue 5 A, 1998, Pages 3241-3245

  Cristiano, Richard J ^a,b  

^a UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

^b Box 109 ^*  (United States)

Author keywords

Adenovirus; Cancer; Gene delivery; Protein DNA polyplex

Indexed keywords

EPIDERMAL GROWTH FACTOR;

ADENOVIRUS; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CANCER CELL CULTURE; CANCER THERAPY; CELL PROLIFERATION; CONTROLLED STUDY; ENDOSOME; EXPRESSION VECTOR; GENE TARGETING; GENE THERAPY; GENETIC TRANSDUCTION; GROWTH INHIBITION; HUMAN; HUMAN CELL; LUNG NON SMALL CELL CANCER; MOUSE; NONHUMAN; PRIORITY JOURNAL; TUMOR GROWTH; TUMOR SUPPRESSOR GENE; VIRUS REPLICATION;

ADENOVIRIDAE; ANIMALS; CARCINOMA, NON-SMALL-CELL LUNG; GENE THERAPY; GENES, P53; GENETIC VECTORS; HUMANS; LUNG NEOPLASMS; MICE; MICE, NUDE; NEOPLASMS; TRANSFECTION; TUMOR CELLS, CULTURED;

EID: 0031729897     PISSN: 02507005     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (27)

1. Roth JA and Cristiano RJ: Gene therapy for cancer: What have we done and where are we going? J Natl Can Inst 89(1): 21-39, 1997.
2. Li Q, Kay M, Woo S: Assessment of recombinant adenoviral vectors for hepatic gene therapy. Human Gene Ther 4: 403-409, 1993.
3. Bender M, Gelinas R, Miller A: A majority of mice show long-term expression of a human ß-globin gene after retrovirus transfer into hematopoietic stem cells. Mol Cell Biol 9:1426-1434, 1989.
4. Nabel E, Gordon D, Yang Z, et al: Gene transfer in vivo with DNA-liposome complexes: lack of autoimmunity and gonadal localization. Human Gene Ther 3: 649-656, 1992.
5. Cristiano RJ, Roth JA: Epidermal growth factor mediated DNA delivery into lung cancer cells via the epidermal growth factor receptor. Cancer Gene Ther 3: 4-10, 1996.
6. Miller D, Adam M, Miller A: Gene transfer by retrovirus vectors only in cells that are actively replicating at the time of infection. Mol Cell Biol 10: 4239-4242, 1990.
7. Marx J: How p53 suppresses cell growth. Science 262:1644-1645.
8. Cusack JC, Spitz F, Nguyen DM, et al: High levels of gene transduction in human lung tumors following intralesional injection of recombinant adenovirus. Cancer Gene Ther 3: 245-249, 1996.
9. Zhang W, Fang X, Mazur W, et al: High-efficiency gene transfer and high-level expression of wild-type p53 in human lung cancer cells mediated by recombinant adenovirus. Cancer Gene Therapy 1: 5-13, 1994.
10. Spitz FR, Nguyen D, Skibber JM, et al: In vivo adenovirus mediated p53 tumor suppressor gene therapy in colorectal cancer. AntiCancer Res 16: 3415-3422, 1996.
11. Srivastava S, Katayose D, Tong YA, et al: Recombinant adenovirus vector expressing wild-type p53 is a potent inhibitor of prostate cancer cell proliferation 46: 843-848, 1995.
12. Putnam EA, Yen N, Gallick GE, et al: Autocrine growth stimulation by transforming growth factor-ύ in human non-small cell lung cancer. Surg Oncol 1: 49-60, 1992.
13. Murphy LD, Valverius EM, Tsokos M, et al: Modulation of EGF receptor expression by differentiating agents in human colon carcinoma cell lines. Cancer Comm 2: 2345-355, 1990.
14. Cristiano R, Smith L, Woo S: Hepatic gene therapy: adenovirus enhancement of receptor-mediated gene delivery and expression in primary hepatocytes. Proc Natl Acad Sci USA 90: 2122-2126, 1993.
15. Curiel DT, Agarwal S, Wagner E, et al: Adenovirus enhancement of transferrin-polylysine-mediated gene delivery. Proc Natl Acad Sci USA 88: 8850-8854, 1991.
16. Zhang Y, Mukhopadhyay T, Donehower LA, et al: Retroviral vector-mediated transduction of K-ras antisense RNA into human lung cancer cells inhibits expression of the malignant phenotype. Human Gene Ther 4: 451-460, 1993.
17. Bergelson JM. Cunningham JA. Droguett G. Kurt-Jones EA. Krithivas A. Hong JS. Horwitz MS. Crowell RL. Finberg RW: Isolation of a common receptor for Coxsackie B viruses and adenoviruses 2 and 5. Science 275: 1320-3, 1997.
18. Wickham TJ, Mathias P, Cheresh DA, et al. Integrins alphav beta 3 and alphav beta 5 promote adenovirus internalization but not virus attachment. Cell 73: 309-319, 1993.
19. Davis H, Whalen R, Demeneix B: Direct gene transfer into skeletal muscle in vivo: factors affecting efficiency of transfer and stability of expression. Human Gene Ther 4: 151-159, 1993.
20. Spitz FR, Nguyen DM, Skibber JM, Meyn RE, Cristiano RJ, Roth JA: Adenoviral-mediated wild-type p53 gene expression sensitizes colorectal cancer cells to ionizing radiation. Clin Cancer Res 2: 1665-1671, 1996.
21. Nguyen DM, Spitz F, Yen N, Cristiano RJ, Roth JA: Gene therapy for lung cancer: enhancement of tumor suppression by a combination of sequential systemic cisplatin and adenovirus-mediated p53 gene transfer. J Thora Cardiovasc Surg 112(5): 1372-1377, 1996.
22. Kaplan JM. Armentano D. Sparer TE. Wynn SG. Peterson PA. Wadsworth SC. Couture KK. Pennington SE. St. George JA. Gooding LR. Smith AE: Characterization of factors involved in modulating persistence of transgene expression from recombinant adenovirus in the mouse lung. Hum Gene Ther 8: 45-56, 1997.
23. Michael SI, Hong JS, Curiel DT, et al: Addition of a short peptide ligand to the adenovirus fiber protein. Gene Therapy 2: 660-668, 1995.
24. Cristiano RJ, Roth JA: Molecular conjugates: a targeted gene delivery vector for molecular medicine. J Mol Med 73: 479-486, 1995.
25. Wagner E, Plank C, Zatloukal K, et al: Influenza virus hemagglutinin HA-2 N-terminal fusogenic peptides augment gene transfer by transferrin-polylysine-DNA complexes: Toward a synthetic virus-like gene-transfer vehicle. Proc Natl Acad Sci USA 89: 7934-7938, 1992.
26. Cristiano RJ and Curiel DT: Strategies to accomplish gene delivery via the receptor-mediated endocytosis pathway. Cancer Gene Ther 49-57, 1996.
27. Xu B, Wiehle S, Roth JA, Cristiano RJ: The contribution of poly-L-lysine, streptavidin, and epidermal growth factor to EGF/PLL/DNA polyplex formation. Gene Therapy (In Press) 1998.